Bruker (BRKR) Stock: Buy, Sell, or Hold?
BRKR - Bruker Corporation
$63.65
1.71 (2.76%)
▲
5d:
-0.83%
30d:
+7.84%
90d:
+3.77%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 02, 2026
30d
Get Alerted When BRKR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BRKR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BRKR shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$74.48
Based on 8.4% avg growth
INTRINSIC VALUE TODAY
$46.24
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BRKR is currently trading at $63.65, which is considered extended relative to its 30-day fair value range of $55.81 to $62.81. From a valuation perspective, the stock is trading at a premium (Forward PE: 25.9) compared to its historical average (20.9). At these levels, the market is pricing in 7.5% annual earnings growth.
Technical Outlook: Technically, BRKR is in a uptrend. Immediate support is located at $59.17, while resistance sits at $66.98.
Market Sentiment: BRKR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BRKR is in a uptrend. Immediate support is located at $59.17, while resistance sits at $66.98.
Market Sentiment: BRKR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$55.81 -
$62.81
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
27.1%
Protect Your Profits
Holding BRKR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($62.08)
- BULLISH: Expecting earnings turnaround to 7.5% growth with 5.2% revenue growth
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$55.81 -
$62.81
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$59.17
Resistance Level
$66.98
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
25.90
Wall Street Target
$62.08
(+0.2%)
Revenue Growth (YoY)
5.2%
Earnings Growth (YoY)
-81.8%
Profit Margin
-2.0%
Valuation Premium vs History
+7.5% premium
PE vs Historical
25.9 vs 20.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.5%
(market-implied from PE analysis)
1-Year Target
$66.59
(+8%)
2-Year Target
$71.58
(+16%)
3-Year Target
$76.95
(+24%)
3-Yr Target (if PE normalizes)
(PE: 26→21)
PE COMPRESSION
$62.08
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.9, Growth: 12.7%)
$88.64
(+43%)
Base:
(SPY PE: 20.4, Growth: 12.7%)
$69.81
(+13%)
Bear:
(PE: 17.3, Growth: 12.7%)
$59.34
(-4%)
Share & Embed Analysis
Last updated: October 02, 2026 2:38 PM ET
Data refreshes hourly during market hours. Next update: 3:38 PM
Data refreshes hourly during market hours. Next update: 3:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BRKR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark Munch
SELL
2000 shares
2026-04-15
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 69 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 51 HOLD |
Advanced BRKR Option Strategies
Professional options setups generated by AI based on today's BRKR price and gamma walls.
